Cannabinoid Receptor-Activating Compounds Killed Brain Cancer Cells in the Lab

What the researchers found

Two fatty ethanolamides (FAA1 and FAA2) reduced C6 glioma cell viability, proliferation, and migratory potential in a dose-dependent manner. They triggered apoptotic cell death through mitochondrial integrity loss, likely by activating cannabinoid receptors and inhibiting the PI3K/Akt signaling pathway. Critically, neither compound was toxic to normal retinal glial cells.

Why it matters

Gliomas are among the most aggressive and treatment-resistant brain cancers, with patients often surviving less than a year after diagnosis. Finding compounds that kill cancer cells while sparing normal cells is the central challenge, and these cannabinoid receptor-activating compounds showed that selectivity.

The numbers in context

Two compounds tested (FAA1 and FAA2). Dose-dependent reduction in glioma cell viability, proliferation, and migration. Apoptosis confirmed via mitochondrial integrity loss. PI3K/Akt pathway inhibition confirmed. No toxicity to normal retinal glial cells.

How the study worked

In vitro study testing two fatty acid amides synthesized from andiroba oil (Carapa guianensis) on C6 glioma cells. Assessments included cell viability, proliferation, migration, mitochondrial membrane potential, and pathway analysis. Normal retinal glial cells were used as a toxicity control.

What this study cannot tell us

In vitro study only; effects in living organisms may differ entirely. C6 glioma cells are a rat cell line and may not fully represent human glioblastoma. The compounds were derived from a specific natural product, and their pharmacokinetics in vivo are unknown.

How to read the evidence

In vitro study with clear mechanistic data, but laboratory cell culture findings are far from clinical application.

When this study was published

2024 study

The bigger picture

The endocannabinoid system has emerged as a target in cancer research. This study adds to the evidence that cannabinoid receptor activation can trigger cancer cell death through established oncological pathways (PI3K/Akt), connecting cannabis science to mainstream cancer biology.

Questions still open

• Would these compounds cross the blood-brain barrier? How do they compare to existing cannabinoid-based anti-tumor compounds? Would they be effective against human glioblastoma cell lines?

Common questions

Read the original research

Fatty Acid Amides Suppress Proliferation via Cannabinoid Receptors and Promote the Apoptosis of C6 Glioma Cells in Association with Akt Signaling Pathway Inhibition.

Pharmaceuticals (Basel, Switzerland), 17(7)

Citation

Silva, Nágila Monteiro da; Lopes, Izabella Carla Silva; Galué-Parra, Adan Jesus; Ferreira, Irlon Maciel; Sena, Chubert Bernardo Castro de; Silva, Edilene Oliveira da; Macchi, Barbarella de Matos; Oliveira, Fábio Rodrigues de; do Nascimento, José Luiz Martins. (2024). Fatty Acid Amides Suppress Proliferation via Cannabinoid Receptors and Promote the Apoptosis of C6 Glioma Cells in Association with Akt Signaling Pathway Inhibition.. Pharmaceuticals (Basel, Switzerland), 17(7). https://doi.org/10.3390/ph17070873

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk